Bristol-Myers Squibb - HIV R&D Assets' Unit Acquisition

Bristol-Myers Squibb - HIV R&D Assets raised a round of funding on December 18, 2015. Investors include ViiV.

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.…

Articles about Bristol-Myers Squibb - HIV R&D Assets' Unit Acquisition: